Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
October 3, 2018
BrainStorm Highlights Translational Data and Presentations Supporting NUROWN® Technology Platform as a Best-In-Class Strategy in ALS
NEW YORK and PETACH TIKVAH, Israel, Oct. 03, 2018 (GLOBE NEWSWIRE) -- BrainStorm Cell Therapeutics Inc. (BCLI), a leading developer of innovative adult stem cell ...
October 3, 2018
ADMA BioCenters Receives FDA Approval for Third Plasma Collection Center
RAMSEY, N.J. and MARIETTA, Ga., Oct. 03, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (ADMA) (“ADMA” or the “Company”), a vertically integrated commercial biopharmaceutical company ...
October 3, 2018
CytoSorbents to Present at the Cantor Fitzgerald Global Healthcare Conference
MONMOUTH JUNCTION, N.J., Oct. 3, 2018 /PRNewswire/ -- CytoSorbents Corporation(CTSO), a critical care immunotherapy leader using its CytoSorb® blood purification technology to treat deadly inflammation in ...
October 3, 2018
Neovasc Announces Positive 12-week Follow-up Data from the First U.S. Patient Implanted with a Neovasc Reducer™
VANCOUVER, Oct. 3, 2018 /PRNewswire/ - Neovasc Inc. ("Neovasc" or the "Company") (NVCN)(NVCN.TO), a leader in the development of minimally invasive transcatheter mitral valve replacement ...
October 3, 2018
Sanford Health Announces Adoption of iCAD's Xoft Electronic Brachytherapy System for Early-Stage Breast Cancer Treatment
NASHUA, N.H. and SIOUX FALLS, S.D., Oct. 03, 2018 (GLOBE NEWSWIRE) -- iCAD, Inc. (ICAD), a global medical technology leader providing innovative cancer detection and therapy ...
October 3, 2018
Altimmune Closes on $16.9 Million in Funding
GAITHERSBURG, Md., Oct. 03, 2018 (GLOBE NEWSWIRE) -- Altimmune, Inc. (ALT), a clinical-stage immunotherapeutics company, today announced it closed the previously announced underwritten public offering ...
October 3, 2018
Achaogen Highlights Multiple Plazomicin Presentations at IDWeek 2018
SOUTH SAN FRANCISCO, Calif., Oct. 03, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (AKAO), a biopharmaceutical company discovering, developing, and commercializing innovative antibacterial agents to address ...
October 3, 2018
MannKind Presents New Scientific Data at 54th Annual Meeting of the European Association for the Study of Diabetes
WESTLAKE VILLAGE, Calif., Oct. 03, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (MNKD), announced that it presented new scientific data in an oral and poster presentation ...
October 3, 2018
CymaBay Therapeutics Announces Additional Positive Results from its Ongoing Phase 2 Study of Seladelpar in Patients with PBC will be Presented During the Late-Breaking Session at The Liver Meeting®
NEWARK, Calif., Oct. 03, 2018 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (CBAY), today announced that two late-breaking presentations describing new long-term data from its ongoing ...
October 3, 2018
Zosano Pharma Engages Contract Manufacturer as Part of the Commercialization Strategy for M207
FREMONT, Calif., Oct. 03, 2018 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (ZSAN) (“Zosano” or the “Company”), a clinical-stage biopharmaceutical company developing and commercializing therapies that deliver ...
September 27, 2018
VALNEVA Raises €50 Million in Oversubscribed Placement Led by US Healthcare Investors
Saint-Herblain (France), September 27th, 2018 - Valneva SE ("Valneva" or "the Company"), a commercial stage biotech company focused on developing innovative lifesaving vaccines, today announced ...
September 27, 2018
EDAP TMS SA : EDAP Announces the Installation of a Third Focal One® HIFU Device in Brazil
LYON, France, September 27, 2018 -- EDAP TMS SA (EDAP), the global leader in therapeutic ultrasound, today announced the installation of the third Focal One ...
September 27, 2018
BioTime to Present at the Upcoming Ladenburg Thalmann and MicroCap Conferences
ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, today announced that Russell Skibsted, Chief Financial Officer, will present ...
September 27, 2018
Aptose Biosciences and CrystalGenomics Announce Issuance of European Patent for CG-806
SAN DIEGO, TORONTO and SEOUL, South Korea, Sept. 27, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), today ...
September 27, 2018
Galmed Pharmaceuticals to Present at the Cantor Global Healthcare Conference, ROTH Battle of the NASH Thrones Investor Conference and Stifel Healthcare Conference
TEL AVIV, Israel, Sept. 27, 2018 /PRNewswire/ --  Galmed Pharmaceuticals Ltd. (GLMD), a clinical-stage biopharmaceutical company focused on the development of the liver targeted SCD1 ...
September 27, 2018
Tyme Technologies, Inc. and the Joseph Ahmed Foundation Announce Planned Trial for SM-88 in Ewing’s Sarcoma
NEW YORK, Sept. 27, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (TYME) today announced that JAF will provide funding and patient support for an investigator-initiated ...
September 27, 2018
Checkpoint Therapeutics to Present at Ladenburg Thalmann 2018 Healthcare Conference
NEW YORK, Sept. 27, 2018 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (CKPT), a Fortress Biotech (FBIO) company, today announced that James F. Oliviero, President ...
September 27, 2018
Vaccinex, Inc. to Participate in Podium and Poster Sessions at the Fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference
ROCHESTER, N.Y., Sept. 27, 2018 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (VCNX), a clinical-stage biotechnology company engaged in the discovery and development of targeted biotherapeutics to treat ...
September 27, 2018
Zealand Pharma has initiated the Phase 3 trial with dasiglucagon for treatment of severe hypoglycemia in children
Copenhagen, September 27, 2018 - Zealand Pharma A/S ("Zealand") (ZEAL), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, today ...
September 27, 2018
InspireMD Announces Presentation of Preliminary Cumulative Three-Year CGuard™ EPS Safety and Efficacy Data at the Transcatheter Cardiovascular Therapeutics 2018 Conference
TEL AVIV, Israel, Sept. 27, 2018 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention ...
Page 35 of 138